Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

NCT01525953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2012-02-03

No results posted yet for this study

Summary

The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer

Conditions

  • Esophageal Cancer

Interventions

DRUG

Chemotherapy

Chemotherapy according to standard

RADIATION

Radiotherapy

Radiotherapy according to local standard

Sponsors & Collaborators

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Antoine ADENIS, MD, PhD · Centre Oscar Lambret

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01525953 on ClinicalTrials.gov